Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD
Impact of Feedback on Physical Activity Levels and Health-related Outcomes of Patients With COPD During Pulmonary Rehabilitation
The aim of this study is to investigate whether providing feedback on physical activity (PA) levels to patients with Chronic Obstructive Pulmonary Disease (COPD) is feasible and enhances daily PA and health-related outcomes during pulmonary rehabilitation (PR).
Patients will participate in a 12-week PR program and a PA-focused intervention. Patients' daily PA will be monitored during the first (W1), seventh (W7) and 12th (W12) weeks of the PR program using the activity monitors GT3X+ (ActiGraph, Pensacola, FL) and feedback will be given to them in the following weeks. Each participant will also receive individualised recommendations to improve or maintain their PA levels, based on the results of the previous week.
It is expected that, by receiving individualised feedback and goals regarding their PA levels during the PR program, patients with COPD will become more active and improve their health-related outcomes.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Patients with Chronic Obstructive Pulmonary Disease (COPD) present lower levels of physical activity (PA), which have been associated with adverse outcomes including increased healthcare utilisation and reduced survival. Thus, improving PA levels has become one of the main goals of COPD research.
Pulmonary rehabilitation (PR) is a cornerstone of COPD management with well-documented effects on exercise capacity and quality of life. However, its effects in increasing patients' physical activity (PA) levels are limited. Previous research has suggested that PR with PA monitoring and feedback may be a suitable approach to increase and/or maintain patients' PA levels.
Patients with COPD will participate in a 12-week PR program plus a PA-focused intervention. Daily PA will be measured using activity monitors GT3X+ (ActiGraph, Pensacola, FL) on weeks (W) 1, 7 and 12 and feedback will be given to participants in the following weeks regarding: daily steps; time spent in sedentary, light and moderate-to-vigorous (MVPA) intensity activities.
The impact of the intervention will be explored using a mixed-methods approach.
Assessments will be conducted immediately before (W1) and after (W12) the PR program. Breathlessness, exercise capacity, functional balance, peripheral muscle strength and health-related quality of life will be assessed in both time points.
Descriptive statistics will be used to characterise the sample. To analyse changes in outcome measures, data from the two time points will be compared. Correlations between PA data and health-related outcomes will be performed at W1 and using the change scores (i.e., W12-W1).
Patients will also be invited to attend focus groups after the intervention to assess their perspectives about the use of activity monitors and the feedback given.
This is a pilot study which will inform the main study (including the sample size calculation).
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- clinical diagnosis of COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria
- ≥ 18 years old
- clinical stability for 1 month prior to the study (no hospital admissions or exacerbations)
Exclusion Criteria:
- presence of severe psychiatric, neurologic or musculoskeletal conditions and/or unstable cardiovascular disease
- participation in regular exercise prior to the study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Activity group
Pulmonary rehabilitation plus physical activity intervention
|
Patients will enrol in a 12-week PR program comprising exercise training (3 times per week) and psychosocial support and education sessions (once a week).
Patients will also have their PA levels monitored on weeks (W) 1, 7 and 12 and receive feedback in the following weeks.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in physical activity levels
Délai: weeks 1, 7 and 12
|
Physical activity data will be collected using a triaxial accelerometer.
Number of steps per day and time spent in sedentary, light and moderate-to-vigorous intensity activities will be assessed.
Time spent in different postures (i.e., standing, sitting and lying) will also be determined.
|
weeks 1, 7 and 12
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in exercise capacity
Délai: immediately before (week 1) and after (week 12) the PR program
|
Exercise tolerance will be assessed with the 6-minute walk test, following the American Thoracic Society guidelines.
The maximal distance walked during 6 minutes and the associated respiratory symptoms will be collected.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Change in peripheral muscle strength
Délai: immediately before (week 1) and after (week 12) the PR program
|
Isometric muscle strength of the upper and lower limbs will be assessed with the 10-RM following the American College of Sports Medicine guidelines.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Change in activities limitation resulting from breathlessness
Délai: immediately before (week 1) and after (week 12) the PR program
|
The Modified British Medical Research Council questionnaire comprises five grades (statements) in a scale from 0 to 4, with higher grades indicating greater perceived respiratory limitation.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Change in functional balance
Délai: immediately before (week 1) and after (week 12) the PR program
|
The Timed Up and Go (TUG) test is a functional balance test in which the time needed to perform the test is recorded.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Change in health-related quality of life
Délai: immediately before (week 1) and after (week 12) the PR program
|
The St. George's Respiratory Questionnaire (SGRQ) is a disease-specific instrument designed to measure quality of life in patients with chronic lung disease.
It has 3 domains: symptoms, activities and impact.
Higher scores indicate poorer quality of life.
|
immediately before (week 1) and after (week 12) the PR program
|
|
Patients' perspectives about the intervention
Délai: Immediately after the PR program (week 12)
|
Semi-structured focus group interviews will be conducted with patients to explore their perspectives about the use of activity monitors and the feedback given.
|
Immediately after the PR program (week 12)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Alda S. Marques, PhD, Aveiro University
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- SFRH /BD/81328/2011
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .